A fresh study, covering “Recombinant Protein Market Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2022” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the Healthcare Market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make the research a powerful source for analysts and industry experts who are looking to gain necessary knowledge about the prevailing market trends, opportunities and drivers present in the Recombinant Protein Market.
Request for Sample Report- www.factmr.com/connectus/sample?flag=S&rep_id=186
Proteins resulting from expression of recombinant DNA (rDNA), within living cells, are known as recombinant proteins. rDNAs are DNA molecules that are formed by laboratory procedures of genetic recombination, to bring genetic material together from multiple sources. DNA sequences used for constructing recombinant DNA molecules originate from any species. If the DNA sequences do not occur in nature, they can be created through chemical synthesis of DNA, further incorporating them into recombinant molecules.
North America to Remain Dominant in the Market
North America will continue to retain its dominance in the global recombinant protein market, with sales projected to reach nearly US$ 150 Mn by 2022-end. Europe is estimated to be the second most lucrative market for recombinant protein throughout the forecast period. The market in Middle East & Africa (MEA) is anticipated to witness a sluggish expansion through 2022.
Recombinant proteins factoring molecular growth will remain the most lucrative product in the market, followed by checkpoint regulators. In addition, sales of growth factors, and cytokines are poised to exhibit similar CAGRs through 2022. However, sales of chemokines are estimated to register the fastest expansion through 2022. Demand for enzymes & inhibitors will continue to be sluggish throughout the forecast period.
Although academic & research institutes are expected to remain the largest end-users of recombinant proteins in terms of revenues, sales in biopharmaceutical companies will register the highest CAGR compared to all the other end-user segments through 2022. Revenues from sales of recombinant proteins in academic & research institutes will account for over one-third market share during 2017 to 2022.
Recombinant proteins will continue to find the largest application in basic research activities. Revenues from recombinant proteins for basic research are expected to account for around US$ 270 Mn by 2022-end. Drug discovery & development, and toxicity screening are estimated to emerge as the fastest growing applications of recombinant proteins. Sales of recombinant proteins for application in forensic testing are estimated to register the lowest CAGR through 2022.
Browse Full Report with TOC- www.factmr.com/report/186/recombinant-protein-market
Table of Content:
1. Global Recombinant Proteins Market – Executive Summary
2. Global Recombinant Proteins Market Overview
2.1.1. Global Recombinant Proteins Market Taxonomy
2.1.2. Global Recombinant Proteins Market Definition
2.2. Global Recombinant Proteins Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global Recombinant Proteins Market Y-o-Y Growth
2.3. Global Recombinant Proteins Market Dynamics
2.5. Supply Chain
2.6. Cost Structure
2.7. Average Pricing Analysis
2.8. List of Distributors
2.9. Key Participants Market Presence (Intensity Map) By Region
3. Global Recombinant Proteins Market Analysis and Forecast By Product Type
3.1. Global Recombinant Proteins Market Size and Forecast By Product Type, 2012-2022
3.1.1. Immune Checkpoint Regulators Recombinant Proteins Market Size and Forecast, 2012-2022
184.108.40.206. Revenue (US$ Mn) Comparison, By Region
220.127.116.11. Market Share Comparison, By Region
18.104.22.168. Y-o-Y growth Comparison, By Region
3.1.2. Chemokines Recombinant Proteins Market Size and Forecast, 2012-2022
22.214.171.124. Revenue (US$ Mn) Comparison, By Region
126.96.36.199. Market Share Comparison, By Region
188.8.131.52. Y-o-Y growth Comparison, By Region
Request Discount on This Report- www.factmr.com/connectus/sample?flag=D&rep_id=186
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.